Advent Life Sciences LLP

Overview

See how the biggest companies compare on our leaderboards

Corporate structure

Advent Life Sciences LLP sits at the top of its group. 4 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.

Investment adviser

Advent Life Sciences LLP is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.

• RegistrationSEC 802-92178, CRD 173031 IAPD record

Who owns it

Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).

• Mohammed Shahzad Ahmed Malikowns 50% to 75%, since 11/2010
• Rajesh Parekhowns 50% to 75%, since 11/2010

Stakes it holds

Advent Life Sciences LLP has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

• Acutus Medical, Inc.SCHEDULE 13G/A Feb 14, 2022 to Feb 17, 2026³
• Aura Investments Ltd.SCHEDULE 13G/A Feb 14, 2022 to Feb 17, 2026⁴
• Eloxx Pharmaceuticals, Inc.SC 13D/A Aug 20, 2024⁵